Why the study?
Due to high cost, TAVI availability varies worldwide, and clinical characteristics and outcomes of TAVI patients had not yet been documented in Egypt.
Answers are grounded in this paper and cite their sources.
The first Egyptian TAVI registry demonstrates acceptable safety and efficacy with in-hospital and 30-day mortality rates comparable to international registries.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bahaa et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: